TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

PHASE2RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Immunotherapy-related Pruritus
Interventions
DRUG

Tricalm Hydrogel

TriCalm Hydrogel® is a topical gel that allows rapid administration to areas of the skin. TriCalm Hydrogel® is available over-the-counter and contains the active ingredient, aluminum acetate 0.2%, and inactive ingredient, strontium chloride hexahydrate.

DRUG

Triamcinolone acetonide 0.1% cream

Triamcinolone acetonide 0.1% cream is a topical steroid cream that will be applied directly to the skin.

Trial Locations (1)

92037

RECRUITING

University of California San Diego, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER